CMA accuses four pharmas of anticompetitive behaviour

23rd May 2019 Uncategorised 0

Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine, costing the NHS millions of pounds and breaking competition law.

More: CMA accuses four pharmas of anticompetitive behaviour
Source: News